Logo

cancer screening

Oxford Team Debuts Multi-Modal MCED Approach Built on Exact Sciences Methylation Sequencing Tech
Premium

The group's TriOx assay sensitively detected cancers, including at early stages, using combined sequencing of methylation and gene alterations.

Dxcover Nabs $6.2M in Funding for Cancer Test Development, Commercialization

The Scotland-based firm said that it will use the money for the development of its cancer tests and commercialization in new markets.

NCI Multi-Cancer Screening Trial Set to Take Off With Selection of Two Liquid Biopsy Tests
Premium

The NCI-led Vanguard study has selected tests from Guardant Health and ClearNote Health to move forward after a vigorous technology assessment.

Volition Eyes East Asia Expansion With Nucleosome-Based Blood Test for Lung Cancer Screening
Premium

The firm hopes to include its lung cancer assay in Taiwan's national cancer screening program while developing sepsis and ovarian cancer assays.

Canadian Oncologists Building Evidence for Gynecologic Cancer Early Detection Test
Premium

The McGill University team is advancing a test, dubbed DOvEEgene, which sequences DNA from a uterine brush sample to detect cancer-associated mutations.

Nov 18, 2024

Colorectal Cancer Screening With Low-Cost FIT Shows Similar Results to Stool-Based DNA Test
Premium

Nov 12, 2024

Mainz Biomed, Thermo Fisher Scientific to Develop Colorectal Cancer Screening Test

Oct 24, 2024

MiRoncol Eyes Next Steps to Commercialize MicroRNA-Based Multi-Cancer Screening Test
Premium

Oct 15, 2024

Tencent Invests $30M in Early Cancer Detection Firm Insighta

Oct 9, 2024

Proteotype Diagnostics, University of Southampton Nab £1.5M to Support MCED Validation

Oct 3, 2024

Researchers Stress Specificity of Grail Multi-Cancer Detection Test in Response to Study Criticism
Premium

Sep 19, 2024

New Multi-Cancer Detection Data Speak to Both Promises and Cautions of Blood-Based Assays
Premium

Sep 17, 2024

Chinese Cancer MDx Firm's Auditor, CFO Resign Amidst Accounting Fraud Allegations

Sep 3, 2024

Lucid Diagnostics Partners With Front Line Mobile to Promote Esophageal Cancer Test

Aug 30, 2024

Hackensack Meridien Health Launches Cancer Risk, Early Detection Program; Eyes Multi-Cancer Testing
Premium

Aug 27, 2024

Imidex, Orbit Genomics Partner to Develop Lung Cancer Detection Technologies

Aug 8, 2024

Guardant Health Q2 Revenues Grow 29 Percent; Firm Raises Full-Year Guidance

Jul 31, 2024

Exact Sciences Reports 12 Percent Q2 Revenue Jump, Breaks Quarterly Test Volume Record

Jul 29, 2024

Guardant Health's Shield Test Approved by FDA as Primary Blood-Based CRC Screening Option

Jul 26, 2024

Predica Diagnostics Developing Targeted Sequencing Test for Cervical Cancer Diagnosis, Screening
Premium

Jul 10, 2024

Surfix Diagnostics, Dutch Partners to Validate Colon Cancer Screening

Jun 4, 2024

Oncologists Contend With Practice Implications of Emerging Multi-Cancer Detection Tests

May 24, 2024

Guardant Health Colon Cancer Screening Test Backed by Majority Amidst Robust Debate in FDA Meeting
Premium

May 13, 2024

Delfi Diagnostics, OSF HealthCare Partner to Expand Blood-Based Lung Cancer Screening

May 10, 2024

Guardant Health Raises Full-Year Guidance as Q1 Revenues Rise 31 Percent